DR. REDDY'S LABORATORIES-ADR (RDY)       53.71  +0.46 (+0.86%)

53.71  +0.46 (+0.86%)

US2561352038 - ADR - After market: 53.71 0 (0%)

Buy % Consensus

Analysts have set a mean price target of 64.17. This target is 19.48% above the current price.
RDY was analyzed by 45 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about RDY.
In the previous month the buy percentage consensus was at a similar level.
RDY was analyzed by 45 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 53.7145.7664.0064.1778.76 - -14.80% 19.17% 19.48% 46.63%

Up and Down Grades

Date Firm Action Rating
2022-10-31 Barclays Maintains Overweight
2022-10-25 Barclays Maintains Overweight
2022-09-12 Barclays Maintains Overweight
2022-07-25 Barclays Maintains Overweight
2022-05-24 Barclays Maintains Overweight
2021-11-01 Barclays Maintains Overweight
2021-07-28 Prabhudas Lilladher Maintains Accumulate
2021-07-28 Axis Direct Maintains Buy
2021-07-28 ICICI Securities Limited Maintains Hold
2021-07-28 Motilal Oswal Maintains Neutral
2021-07-27 Axis Direct Maintains Buy
2021-06-23 Axis Direct Maintains Buy
2021-05-19 Geojit BNP Paribas Maintains Buy
2021-05-17 Axis Direct Maintains Buy
2021-05-17 HDFC Securities Maintains Accumulate
2021-05-17 SMC online Maintains
2021-05-15 Prabhudas Lilladher Maintains Accumulate
2021-05-15 ICICI Securities Limited Maintains Hold
2021-05-15 Motilal Oswal Maintains Neutral
2021-04-13 Axis Direct Maintains Buy
2021-03-10 Nirmal Bang Maintains Buy
2021-03-10 Nirmal Bang Institutional Maintains Buy

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA